Sign in
Not yet taking people in SpainPhase 4

Gadopiclenol versus gadobutrol contrast dye for MRI scans of Crohn's disease perianal fistula

Compares two MRI contrast dyes for spotting perianal fistulas in adults with Crohn's disease.

Key facts

Who runs it
Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Where
Barcelona, SpainSee the site
Registry title
Phase IV, single-center, randomized, crossover clinical trial to validate the use of gadopiclenol versus gadobutrol in the evaluation of magnetic resonance imaging (MRI) diagnosis of perianal fistula associated with Crohn's disease
Status
Not yet recruiting
Phase
Phase 4
People taking part
30 people, planned
Started
1 Dec 2025
Expected to end
1 Oct 2027
Type of study
Interventional
Record updated
18 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with Crohn's disease who also have a perianal fistula (a tunnel near the anus) caused by it. It compares two MRI contrast agents.

Age
18 years or older
Sex
All sexes can join
Disease stage
Crohn's disease with perianal disease caused by it

Main reasons for not taking part

  • Younger than 18 years
  • Pregnant or breastfeeding
  • Kidney failure (GFR below 30 ml/min in lab results up to 6 months old)
  • Past allergic reaction to gadolinium contrast media
  • Crohn's disease without perianal disease

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients of legal age with Crohn's disease and perianal disease attributable to their condition
  • Subjects with onset of Crohn's disease with perianal disease
  • Sign informed consent

Who cannot take part

  • History of hypersensitivity reaction to gadolinium-containing contrast media
  • Patients with Crohn's disease without perianal disease
  • Renal failure (GFR ˂30 ml/min in recent laboratory values up to 6 months old)
  • Age ˂18 years
  • Pregnancy and/or breastfeeding

Where in Spain

  • Hospital Universitari Vall d'HebronBarcelona, SpainNot yet recruiting

About the trial

What the trial wants to find out

To validate the use of 0.05 mmol/kg of Gadopiclenol in the detection and monitoring of perianal fistulas by magnetic resonance imaging studies.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Phase IV, single-center, randomized, crossover clinical trial to validate the use of gadopiclenol versus gadobutrol in the evaluation of magnetic resonance imaging (MRI) diagnosis of perianal fistula associated with Crohn's disease
Plain-language title
Gadopiclenol versus gadobutrol contrast dye for MRI scans of Crohn's disease perianal fistulaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
18 December 2025